. Author manuscript; available in PMC: 2015 Feb 1.

Published in final edited form as: HIV Med. 2013 Sep 11;15(2):108–115. doi: 10.1111/hiv.12086

Table 2.

Univariable and multivariable analysis with SVR12 as the outcome

	OR univariable	p-value univariable	OR multivariable	p-value multivariable
Age, year	1.00 (0.97–1.04)	0.89
Sex, female	1.02 (0.51–2.06)	0.95
HIV infected	2.10 (0.96–4.63)	0.07	3.55 (1.44–8.75)	< 0.01
Race, African American	0.50 (0.22–1.12)	0.09	0.37 (0.15–0.92)	0.03
Response, non- responder/intolerant	0.55 (0.29–1.06)	0.07	0.46 (0.23–0.93)	0.03
Log HCV VL	0.91 (0.60–1.37)	0.65
BMI, kg/m²,	0.97 (0.90–1.04)	0.34
Advanced fibrosis/cirrhosis	0.63 (0.32–1.25)	0.19
Diabetes	0.62 (0.24–1.58)	0.31
Treatment site, JHU	2.09 (0.72–6.10)	0.18

OR: Odds ratio; Log HCV VL: logarithm of hepatitis C viral load; body mass index; JHU: John Hopkins University